Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rebooting immunity in congenital athymia: Factors impacting reconstitution with thymus implantation.

Journal of human immunity·2026
Same author

Balancing brain exposure, pharmacokinetics and safety of transferrin receptor antibodies for delivery of neuro-therapeutics.

mAbs·2025
Same author

Renal Single-Nuclear Transcriptomics Identifies Novel Therapeutic Targets in a Preclinical Model of CKD.

Kidney360·2025
Same author

POMC neurons control fertility through differential signaling of MC4R in kisspeptin neurons.

eLife·2025
Same author

A New Model of Chronic Kidney Disease, Metabolic Derangements, and Heart Failure with Preserved Ejection Fraction in Aging Swine.

American journal of nephrology·2025
Same author

POMC neurons control fertility through differential signaling of MC4R in Kisspeptin neurons.

bioRxiv : the preprint server for biology·2024
Same journal

A novel JAK1 mutation identified in a patient with severe atopic dermatitis phenotype: Mechanistic insights and IL-4Rα targeted therapy.

Clinical immunology (Orlando, Fla.)·2026
Same journal

VNN1 aggravates sepsis by promoting inflammation and oxidative stress through PPARγ signaling VNN1 in sepsis.

Clinical immunology (Orlando, Fla.)·2026
Same journal

Comparison between glioblastoma and brain metastases: How epigenetic remodeling can enhance immunotherapy.

Clinical immunology (Orlando, Fla.)·2026
Same journal

JAK-STAT3-MYC axis defines pathogenic stem cell-like memory CD4<sup>+</sup> T cells in rheumatoid arthritis.

Clinical immunology (Orlando, Fla.)·2026
Same journal

The baseline vaginal immune milieu is an important determinant of the inflammatory response induced by penile-vaginal sex.

Clinical immunology (Orlando, Fla.)·2026
Same journal

Adulthood diagnosis of Nijmegen breakage syndrome in twins with antibody deficiency clinical presentation.

Clinical immunology (Orlando, Fla.)·2026
See all related articles

Related Experiment Video

Updated: Jun 15, 2026

Isolation and Transplantation of Different Aged Murine Thymic Grafts.
05:47

Isolation and Transplantation of Different Aged Murine Thymic Grafts.

Published on: May 13, 2015

Thymus transplantation.

M Louise Markert1, Blythe H Devlin, Elizabeth A McCarthy

  • 1Department of Pediatrics, Duke University Medical Center, Durham, NC 27710, USA. marke001@mc.duke.edu

Clinical Immunology (Orlando, Fla.)
|March 19, 2010
PubMed
Summary
This summary is machine-generated.

Thymus transplantation successfully restored naive T cells in infants with complete DiGeorge anomaly, enabling them to discontinue antibiotics and immunoglobulin therapy. This investigational therapy shows promising results for severe primary immunodeficiency.

More Related Videos

Intravital Imaging of the Mouse Thymus using 2-Photon Microscopy
10:08

Intravital Imaging of the Mouse Thymus using 2-Photon Microscopy

Published on: January 7, 2012

Renal Subcapsular Transplantation of 2'-Deoxyguanosine-Treated Murine Embryonic Thymus in Nude Mice
07:39

Renal Subcapsular Transplantation of 2'-Deoxyguanosine-Treated Murine Embryonic Thymus in Nude Mice

Published on: July 19, 2019

Related Experiment Videos

Last Updated: Jun 15, 2026

Isolation and Transplantation of Different Aged Murine Thymic Grafts.
05:47

Isolation and Transplantation of Different Aged Murine Thymic Grafts.

Published on: May 13, 2015

Intravital Imaging of the Mouse Thymus using 2-Photon Microscopy
10:08

Intravital Imaging of the Mouse Thymus using 2-Photon Microscopy

Published on: January 7, 2012

Renal Subcapsular Transplantation of 2'-Deoxyguanosine-Treated Murine Embryonic Thymus in Nude Mice
07:39

Renal Subcapsular Transplantation of 2'-Deoxyguanosine-Treated Murine Embryonic Thymus in Nude Mice

Published on: July 19, 2019

Area of Science:

  • Immunology
  • Developmental Biology
  • Transplantation Science

Background:

  • Infants born without a thymus (athymia) suffer from severe primary immunodeficiency due to a lack of T cell development.
  • Complete DiGeorge anomaly is characterized by the absence of a detectable thymus and naive T cells (CD45RA(+), CD62L(+)).

Purpose of the Study:

  • To evaluate the efficacy and safety of thymus transplantation in infants with complete DiGeorge anomaly.
  • To assess the potential for immune reconstitution and clinical improvement following thymus transplantation.

Main Methods:

  • Sixty infants under 2 years old with complete DiGeorge anomaly received postnatal allogeneic cultured thymus tissue transplantation.
  • Recipient outcomes, including survival, T cell development, and need for supportive therapies, were monitored.

Main Results:

  • Recipient survival exceeded 70% following thymus transplantation.
  • Naive T cells developed in recipients within 3-5 months post-transplantation.
  • Graft recipients were able to discontinue antibiotic prophylaxis and immunoglobulin replacement therapy.

Conclusions:

  • Postnatal allogeneic cultured thymus tissue transplantation is a viable therapeutic option for infants with complete DiGeorge anomaly.
  • The procedure facilitates immune reconstitution, leading to significant clinical improvements and reduced reliance on supportive care.
  • Further research is ongoing to understand the mechanisms of immune reconstitution after thymus transplantation.